Drug Related Problems Pasien Hipertensi di KLinik "X" Kota Bengkulu Periode 2024

Main Article Content

Nina Anggraini
Tri Yanuarto
Luky Dharmayanti

Abstract

Hypertension prevalence data in Indonesia shows that nearly one-third of the adult population suffers from hypertension, which often leads to serious complications such as stroke and kidney failure if not properly treated. Hypertension management requires rational therapy, but often faces Drug-Related Problems (DRPs) that can compromise treatment success. This study aimed to identify DRPs in hypertensive patients at the Clinic “X” in Bengkulu from January to December 2024. The study used a retrospective descriptive design, with medical records of 111 patients reviewed. Results showed that the majority of patients were aged 45–54 years (45.05%) and 55–64 years (35.14%), with a higher proportion of women (54.05%). The most common hypertension classification was stage I (45.95%), followed by prehypertension (27.93%). The DRPs identified included medications without indications, inappropriate medications, too high doses, too low doses, and the need for additional medications. Identification of DRPs is expected to help improve treatment rationality and the quality of clinical pharmacy services, and can serve as a basis for evaluating hypertension therapy management in healthcare facilities.

Article Details

How to Cite
Anggraini, N., Tri Yanuarto, & Luky Dharmayanti. (2026). Drug Related Problems Pasien Hipertensi di KLinik "X" Kota Bengkulu Periode 2024. Jurnal Komunitas Farmasi Nasional, 6(01). Retrieved from https://jkfn.akfaryarsiptk.ac.id/index.php/jkfn/article/view/177
Section
Articles

References

Cipolle, R. J., Strand, L. M., & Morley, P. C. (2012). Pharmaceutical Care Practice: The Patient-Centered Approach to Mediction Management, 3rd Edition. The McGraw-Hill Companies, Inc, 3.

Dipiro, J. T., Talbert, R. L., Yee, G. C., Matzke, G. R., Wells, B. G., & Posey, M. L. (2023). 8TH Edition Pharmacotherapy APathophysiologic Approach. Dalam New York: McGraw -Hill, (Vol. 53, Nomor 9).

Khusna, N., & Murdiana, H. E. (2021). Identifikasi Drug Related Problems (Drps) Obat Antihipertensi Pada Pasien Hipertensi Di Puskesmas Dharma Rini Temanggung. Jurnal Farmasi Dan Kesehatan Indonesia, 1(2), 13–26.

Laura, A., Darmayanti, A., & Hasni, D. (2020). Evaluasi Penggunaan Obat Antihipertensi Di Puskesma$s Ikur Koto Kota Padang Periode 2018. Human Care Journal, 5(2), 570

Mantang, A., Useng, Y., & Pusmarani, J. (2023). Hubungan Drug Related Problems (DRP) Kategori Interaksi Obat Pada Penggunaan Obat Pasien Hipertensi di Puskesmas Lalonggasumeeto Kabupaten Konawe. Jurnal Pharmacia Mandala Waluya, 2(5), 286–294.

Mila, Irawan, Y., & Fakhruddin. (2021). Evaluasi Kerasionalan Penggunaan Antihipertensi Pada Pasien Hipertensi Di Instalasi Rawat Inap RSUD Sultan Imanuddin Palangkaraya BUN 2018. Jurnal Borneo Cendekia, 5(1), 105–111.

Oktianti, D., Furdiyanti, N. H., Fajriani, W. N., & Ambarsari, U. (2020). Evaluasi Terapi Antihipertensi Pada Pasien Rawat Inap Di RS X di Semarang. Indonesian Journal of Pharmacy and Natural Product, 3(1), 25–35.

Tuloli, T. S., Sy. Pakaya, M., & Dwi pratiwi, S. (2021). Identifikasi Drug Related Problems (DRPs) Pasien Hipertensi di RS Multazam Kota Gorontalo. Indonesian Journal of Pharmaceutical Education, 1(1), 1–9.

(WHO), WHO. (2023). Hypertension. http://www.who.int/news-room/fact-sheets/detail/hypertension